Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Greater Risk Of Breast Cancer In Women Exposed To Negative Life Events
http://www.medicalnewstoday.com/articles/119198.php
Happiness and optimism may play a role against breast cancer while adverse life events can increase the risk of developing the disease, according to a study by Professor Ronit Peled, at Ben-Gurion University of the Negev in Israel.
----------------------------------------------
** CANCER / ONCOLOGY News **
Image Guided Radiation Therapy In Latham, NY. Now Fighting Cancer Using Fast And Precise RapidArc™ Radiotherapy Technology
http://www.medicalnewstoday.com/articles/119274.php
Clinicians from the Image Guided Radiation Therapy program at Community Care Physicians in Latham have commenced treating cancer patients using RapidArc™ radiotherapy technology from Varian Medical Systems (NYSE: VAR), an advancement that delivers a highly-precise image-guided, intensity-modulated radiotherapy (IMRT) treatment in two minutes or less.
Zoledronic Acid Improves Bone-Mineral Density Loss In Premenopausal Patients Using Endocrine Therapies For Early Stage Breast Cancer
http://www.medicalnewstoday.com/articles/119271.php
When simultaneously administered, zoledronic acid partnered withadjuvant endocrine therapy prevents bone loss in women with breastcancer, and improved bone-mineral density after treatment, according toan article released on August 20, 2008 in <i>The Lancet Oncology</i>.
Mathematical Model Allows Estimation Of Minimal Detectable Tumor Sizes
http://www.medicalnewstoday.com/articles/119270.php
A novel method of modeling could allow scientists to screen for cancerat an early stage using a blood biomarker, according to an articlereleased on August 19, 2008 in the open-access journal <i>PLoSMedicine</i>.
New Trial To Evaluate Nexavar® As Adjuvant Therapy In Liver Cancer
http://www.medicalnewstoday.com/articles/119266.php
Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. announced the start of a Phase III study with Nexavar® (sorafenib) tablets in liver cancer. The randomized, double-blind, placebo-controlled study is evaluating Nexavar as an adjuvant therapy for patients with hepatocellular carcinoma (HCC), or primary liver cancer.
Normalizing Tumor Vessels To Improve Cancer Therapy
http://www.medicalnewstoday.com/articles/119261.php
Chemotherapy drugs often never reach the tumors they're intended to treat, and radiation therapy is not always effective, because the blood vessels feeding the tumors are abnormal "leaky and twisty" in the words of the late Judah Folkman, MD, founder of the Vascular Biology program at Children's Hospital Boston.
First Major Medical Meeting Convening For MRI-guided Focused Ultrasound To Treat Cancer, Stroke, Fibroids, Other Conditions
http://www.medicalnewstoday.com/articles/119258.php
The Focused Ultrasound Surgery Foundation is pleased to announce the convening of the first major International Symposium dedicated to the current and future use of magnetic resonance guided focused ultrasound surgery (MRgFUS) -- a breakthrough therapeutic technology for treating a variety of serious medical conditions including cancer, neurological disorders, and uterine fibroids.
Image Guided Radiation Therapy In Latham, NY. Now Fighting Cancer Using Fast And Precise RapidArc(TM) Radiotherapy Technology
http://www.medicalnewstoday.com/articles/119256.php
Clinicians from the Image Guided Radiation Therapy program at Community Care Physicians in Latham have commenced treating cancer patients using RapidArc(TM) radiotherapy technology from Varian Medical Systems (NYSE: VAR), an advancement that delivers a highly-precise image-guided, intensity-modulated radiotherapy (IMRT) treatment in two minutes or less.
Gene That Causes Childhood Cancer Neuroblastoma Is Found
http://www.medicalnewstoday.com/articles/119254.php
Scientists have discovered gene mutations that are the main cause of the inherited version of the childhood cancer neuroblastoma. In addition, the researchers found that the same mutations play a significant role in high-risk forms of non-inherited neuroblastoma, the more common form of the disease.
Synta Announces Publication Of Elesclomol Mechanism Of Action Results In AACR Journal Molecular Cancer Therapeutics
http://www.medicalnewstoday.com/articles/119209.php
Synta Pharmaceuticals Corp., (NASDAQ: SNTA) announced the publication of new findings in the American Association for Cancer Research journal, <i>Molecular Cancer Therapeutics</i> that describe the novel mechanism of action of elesclomol: driving programmed cell death (apoptosis) in cancer cells through the selective induction of oxidative stress.
MMRC Partners With Celgene Corporation On Phase I/II Trial Of Pomalidomide In Relapsed And Refractory Multiple Myeloma Patients
http://www.medicalnewstoday.com/articles/119205.php
The Multiple Myeloma Research Consortium (MMRC) announced the initiation of a clinical trial with the oral immunomodulatory agent pomalidomide (CC-4047) in patients who have received at least two prior therapies including treatments with REVLIMID® (lenalidomide) and VELCADE® (bortezomib) for Injection.
SNM Co-Sponsors Radiation Oncology And Cancer Imaging Symposium With American Society For Therapeutic Radiation And Oncology
http://www.medicalnewstoday.com/articles/119192.php
SNM and the American Society for Therapeutic Radiation and Oncology (ASTRO) will cosponsor a symposium this fall examining the impact of translational advances on radiation oncology and cancer imaging.
Experimental Next-Generation Anti-Cancer Therapies Featured In Scientific American
http://www.medicalnewstoday.com/articles/119190.php
<i>Scientific American</i> magazine focused on two University of Alabama at Birmingham (UAB) Comprehensive Cancer Center researchers in a news story on experimental next-generation anti-cancer therapies.
Early Cancer Detection Can Save Lives - Royal Australian College Of General Practitioners
http://www.medicalnewstoday.com/articles/119186.php
On Daffodil Day, 22 August, the Royal Australian College of General Practitioners (RACGP) called for early detection of cancer to improve the patient's chance of successful treatment. Daffodil Day is an initiative of The Cancer Council Australia and reminds us of the importance of raising cancer awareness.
HSC-Institute Of Biosciences And Technology Researchers Learn About Role Of Mutated DNA Repeats In Diseases Like Cancer
http://www.medicalnewstoday.com/articles/119183.php
Researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology in Houston have uncovered new information about the role of certain mutated segments of DNA in forming diseases like cancer.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Moffitt Cancer Center Awarded $2 Million Grant For HPV Vaccination Study
http://www.medicalnewstoday.com/articles/119280.php
The <a href="http://www3.niaid.nih.gov/" target="_blank" rel="nofollow">National Institute of Allergy and Infectious Diseases </a> of the <a href="http://www.nih.gov/" target="_blank" rel="nofollow">National Institutes of Health </a> has awarded a $2 million grant to <a href="http://www.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
MMRC Partners With Celgene Corporation On Phase I/II Trial Of Pomalidomide In Relapsed And Refractory Multiple Myeloma Patients
http://www.medicalnewstoday.com/articles/119205.php
The Multiple Myeloma Research Consortium (MMRC) announced the initiation of a clinical trial with the oral immunomodulatory agent pomalidomide (CC-4047) in patients who have received at least two prior therapies including treatments with REVLIMID® (lenalidomide) and VELCADE® (bortezomib) for Injection.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
No news for this category today.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment